These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
303 related articles for article (PubMed ID: 22208138)
1. Isoniazid preventive therapy programmes for healthcare workers in India: translating evidence into policy. Raj R; Prasad H; Arya BK; Bhattacharya SD Natl Med J India; 2011; 24(4):201-7. PubMed ID: 22208138 [TBL] [Abstract][Full Text] [Related]
2. A quantitative benefit-risk analysis of isoniazid for treatment of latent tuberculosis infection using incremental benefit framework. Sadatsafavi M; Marra C; Marra F; Moran O; FitzGerald JM; Lynd L Value Health; 2013; 16(1):66-75. PubMed ID: 23337217 [TBL] [Abstract][Full Text] [Related]
3. Isoniazid preventive therapy for people living with HIV: public health challenges and implementation issues. Aït-Khaled N; Alarcon E; Bissell K; Boillot F; Caminero JA; Chiang CY; Clevenbergh P; Dlodlo R; Enarson DA; Enarson P; Ferroussier O; Fujiwara PI; Harries AD; Heldal E; Hinderaker SG; Kim SJ; Lienhardt C; Rieder HL; Rusen ID; Trébucq A; Van Deun A; Wilson N Int J Tuberc Lung Dis; 2009 Aug; 13(8):927-35. PubMed ID: 19723371 [TBL] [Abstract][Full Text] [Related]
4. Tuberculin skin test and isoniazid prophylaxis among health care workers in high tuberculosis prevalence areas. Khawcharoenporn T; Apisarnthanarak A; Sungkanuparph S; Woeltje KF; Fraser VJ Int J Tuberc Lung Dis; 2011 Jan; 15(1):14-23. PubMed ID: 21276291 [TBL] [Abstract][Full Text] [Related]
5. Tuberculosis vaccination versus isoniazid preventive therapy: a decision analysis to determine the preferred strategy of tuberculosis prevention in HIV-infected adults in the developing world. Sterling TR; Brehm WT; Moore RD; Chaisson RE Int J Tuberc Lung Dis; 1999 Mar; 3(3):248-54. PubMed ID: 10094327 [TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of including tuberculin skin testing in an IPT program for HIV-infected persons in Uganda. Shrestha RK; Mugisha B; Bunnell R; Mermin J; Hitimana-Lukanika C; Odeke R; Madra P; Adatu F; Blandford JM Int J Tuberc Lung Dis; 2006 Jun; 10(6):656-62. PubMed ID: 16776453 [TBL] [Abstract][Full Text] [Related]
7. BCG vaccination to prevent tuberculosis in health care workers: a decision analysis. Marcus AM; Rose DN; Sacks HS; Schechter CB Prev Med; 1997; 26(2):201-7. PubMed ID: 9085388 [TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness of isoniazid chemoprevention in close contacts. Diel R; Nienhaus A; Schaberg T Eur Respir J; 2005 Sep; 26(3):465-73. PubMed ID: 16135730 [TBL] [Abstract][Full Text] [Related]
9. The cost of intensified case finding and isoniazid preventive therapy for HIV-infected patients in Battambang, Cambodia. Sutton BS; Arias MS; Chheng P; Eang MT; Kimerling ME Int J Tuberc Lung Dis; 2009 Jun; 13(6):713-8. PubMed ID: 19460246 [TBL] [Abstract][Full Text] [Related]
10. [Effectiveness of interventions for the control and prevention of tuberculosis in health care facilities: a review of ATS,CDC, OSHA recommendations]. Franchi A; Banfi MB; Franco G Med Lav; 2003; 94(6):506-20. PubMed ID: 14768243 [TBL] [Abstract][Full Text] [Related]
11. Contact screening and chemoprophylaxis in India's Revised Tuberculosis Control Programme: a situational analysis. Banu Rekha VV; Jagarajamma K; Wares F; Chandrasekaran V; Swaminathan S Int J Tuberc Lung Dis; 2009 Dec; 13(12):1507-12. PubMed ID: 19919768 [TBL] [Abstract][Full Text] [Related]
12. Prospective randomized control trial of isoniazid chemoprophylaxis during renal replacement therapy. Vikrant S; Agarwal SK; Gupta S; Bhowmik D; Tiwari SC; Dash SC; Guleria S; Mehta SN Transpl Infect Dis; 2005; 7(3-4):99-108. PubMed ID: 16390397 [TBL] [Abstract][Full Text] [Related]
13. Preventive chemotherapy for HIV-associated tuberculosis in Uganda: an operational assessment at a voluntary counselling and testing centre. Aisu T; Raviglione MC; van Praag E; Eriki P; Narain JP; Barugahare L; Tembo G; McFarland D; Engwau FA AIDS; 1995 Mar; 9(3):267-73. PubMed ID: 7755915 [TBL] [Abstract][Full Text] [Related]
14. Improving screening and chemoprophylaxis among child contacts in India's RNTCP: a pilot study. Rekha B; Jagarajamma K; Chandrasekaran V; Wares F; Sivanandham R; Swaminathan S Int J Tuberc Lung Dis; 2013 Feb; 17(2):163-8. PubMed ID: 23317950 [TBL] [Abstract][Full Text] [Related]
16. Enhanced cost-benefit analysis of strategies for LTBI screening and INH chemoprevention in Germany. Diel R; Schaberg T; Loddenkemper R; Welte T; Nienhaus A Respir Med; 2009 Dec; 103(12):1838-53. PubMed ID: 19682884 [TBL] [Abstract][Full Text] [Related]
17. Postpartum tuberculosis incidence and mortality among HIV-infected women and their infants in Pune, India, 2002-2005. Gupta A; Nayak U; Ram M; Bhosale R; Patil S; Basavraj A; Kakrani A; Philip S; Desai D; Sastry J; Bollinger RC; Clin Infect Dis; 2007 Jul; 45(2):241-9. PubMed ID: 17578786 [TBL] [Abstract][Full Text] [Related]
18. Isoniazid preventive therapy and 4-year incidence of pulmonary tuberculosis among HIV-infected Thai patients. Khawcharoenporn T; Apisarnthanarak A; Manosuthi W; Sungkanuparph S; Mundy LM Int J Tuberc Lung Dis; 2012; 16(3):336-41. PubMed ID: 22230143 [TBL] [Abstract][Full Text] [Related]
19. Risk of tuberculosis infection and disease associated with work in health care settings. Menzies D; Joshi R; Pai M Int J Tuberc Lung Dis; 2007 Jun; 11(6):593-605. PubMed ID: 17519089 [TBL] [Abstract][Full Text] [Related]
20. Agents of change: The role of healthcare workers in the prevention of nosocomial and occupational tuberculosis. Nathavitharana RR; Bond P; Dramowski A; Kotze K; Lederer P; Oxley I; Peters JA; Rossouw C; van der Westhuizen HM; Willems B; Ting TX; von Delft A; von Delft D; Duarte R; Nardell E; Zumla A Presse Med; 2017 Mar; 46(2 Pt 2):e53-e62. PubMed ID: 28256382 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]